New Gram-positive agents in nosocomial infection

被引：12

作者：

Patterson, JE ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, Dept Med Infect Dis, San Antonio, TX 78229 USA

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 2000年 / 13卷 / 06期

关键词：

D O I：

10.1097/00001432-200012000-00003

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Multidrug-resistant Gram-positive pathogens such as vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci account for a significant number of nosocomial infections, and new options for therapy have been lacking. During the past year, two agents have been released that have activity against these organisms: quinupristin/ dalfopristin and linezolid. Although neither agent is a panacea, these recently released agents offer new options for therapy. Curr Opin Infect Dis 13:593-598. (C) 2000 Lippincott Williams & Wilkins.

引用

页码：593 / 598

页数：6

共 32 条

[1]

[Anonymous], MMWR MORB MORTAL WKL

[2]

BIRMINGHAM MC, 1999, 39 ANN INT C ANT AG

[3] Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections [J].

Chien, JW ;

Kucia, ML ;

Salata, RA .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :146-151

[4] Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia [J].

Chow, JW ;

Donabedian, SM ;

Zervos, MJ .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :90-91

[5] Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy [J].

Chow, JW ;

Davidson, A ;

Sanford, E ;

Zervos, MJ .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :91-92

[6] Linezolid [J].

Clemett, D ;

Markham, A .

DRUGS, 2000, 59 (04) :815-827

[7]

Cupo-Abbott J, 2000, FORMULARY, V35, P483

[8] Oxazolidinones - A review [J].

Diekema, DJ ;

Jones, RN .

DRUGS, 2000, 59 (01) :7-16

[9] Treatment of gram-positive nosocomial pneumonia - Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin [J].

Fagon, JY ;

Patrick, H ;

Haas, DW ;

Torres, A ;

Gibert, C ;

Cheadle, WG ;

Falcone, RE ;

Anholm, JD ;

Paganin, F ;

Fabian, TC ;

Lilienthal, F .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (03) :753-762

[10]

Food and drug administration, 2000, FDA APPR ZYV 1 ANT D

← 1 2 3 4 →